questionText: To ask the Secretary of State for Health and Social Care, with reference to the draft Value Based Procurement guidance for Medical Technology, (a) whether procurement assessments are expected to include comparison with the existing standard of care, (b) how incremental clinical benefit is expected to be measured where a medical device is assessed against an existing treatment pathway, and (c) what weighting is given to clinical outcome evidence relative to cost data in Value Based Procurement assessments.
answerText: The Value Based Procurement (VBP) guidance, published on 11 June 2026, applies to medical technology as defined by the Medical Device Regulations 2002. This includes consumables, implants, diagnostics, equipment and digital technologies. The Department wo...
heading: Medical Equipment: Procurement